Ibandronate Sodium Tablets
Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- SPE2D2-25-R-0019
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is planning to issue a solicitation for Ibandronate Sodium Tablets, specifically 150MG tablets in 3 count packs. This national requirements contract will serve multiple federal agencies including the Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons through DLA and VA prime vendor programs. The procurement will be conducted as an unrestricted and fully competitive acquisition under FAR Part 12 commercial item procedures. The contract structure will be a firm-fixed price requirements contract featuring a one-year base period with four one-year option periods. The projected solicitation date is July 2025, though DLA reserves the right to issue the solicitation before or after this timeframe. Interested parties can contact Christopher Newman at 445-737-7371 or christopher.newman@dla.mil for questions and should establish automated notifications for any pre-solicitation or solicitation changes.
This opportunity carries no set-aside designation, making it available to all qualified sources regardless of size or socioeconomic status. The contract will establish a national supply source in accordance with FAR 52.216-21 Requirements clause, ensuring consistent availability across all participating agencies. Annual usage estimates will be detailed in the Schedule of Supplies section when the formal solicitation is released. The solicitation will be posted on both the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/. The procurement falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing and PSC code 6505 for Drugs and Biologicals. No current contractor or incumbent information was provided in this pre-solicitation notice, nor were specific award values or budget ranges disclosed.
Notice text
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Ibandronate Sodium Tablets. Procurement details follow.
Ibandronate Sodium 150MG in 3 count packs. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/. Interested parties should contact Christopher Newman (445-737-7371) (christopher.newman@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is July of 2025. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Ibandronate Sodium Tablets | Award Notice | |
| Ibandronate Sodium Tablets | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| 6505--Sodium Bicarbonate Injection Vial Restricted to Made in America | National Acquisition Center | No set-aside | |
| Methylphenidate ER | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity